Enanta Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.12 M | $25.40 M | 0.00% | 9.95% |
| KRENSAVAGE ASSET MANAGEMENT, LLC | 11/17/2025 | 2.11 M | $25.31 M | 0.00% | 9.92% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 1.95 M | $23.29 M | 271.73% | 9.13% |
| VANGUARD GROUP INC | 11/07/2025 | 1.94 M | $23.21 M | -1.91% | 9.09% |
| BLACKROCK, INC. | 11/12/2025 | 1.83 M | $21.94 M | -0.75% | 8.60% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 948.08 K | $11.35 M | -35.00% | 4.45% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 867.04 K | $10.37 M | 0.00% | 4.07% |
| COMMODORE CAPITAL LP | 11/14/2025 | 800.00 K | $9.58 M | 100.00% | 3.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 493.19 K | $5.90 M | 1.52% | 2.31% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 479.60 K | $5.74 M | 2.15% | 2.25% |
| STATE STREET CORP | 11/14/2025 | 471.99 K | $5.65 M | 0.37% | 2.21% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 305.00 K | $3.65 M | -49.51% | 1.43% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 300.00 K | $3.59 M | 100.00% | 1.41% |
| MORGAN STANLEY | 11/14/2025 | 282.63 K | $3.38 M | -1.36% | 1.33% |
| MARSHALL WACE, LLP | 11/13/2025 | 275.39 K | $3.30 M | -67.88% | 1.29% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 270.07 K | $3.24 M | -2.73% | 1.27% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 226.85 K | $2.72 M | -42.73% | 1.06% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 225.74 K | $2.70 M | -20.03% | 1.06% |
| NORTHERN TRUST CORP | 11/14/2025 | 195.90 K | $2.34 M | -22.02% | 0.92% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 190.40 K | $2.28 M | 280.80% | 0.89% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 169.05 K | $2.02 M | -11.99% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 166.55 K | $1.99 M | 1.15% | 0.78% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 166.43 K | $1.99 M | 43.31% | 0.78% |
| NUVEEN, LLC | 11/12/2025 | 164.76 K | $1.97 M | 267.07% | 0.77% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 127.36 K | $1.52 M | -51.93% | 0.60% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 126.66 K | $1.52 M | 0.00% | 0.59% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 125.10 K | $1.50 M | -6.36% | 0.59% |
| JPMORGAN CHASE & CO | 11/26/2025 | 123.82 K | $1.48 M | -5.07% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 117.30 K | $1.40 M | 59.04% | 0.55% |
| PDT PARTNERS, LLC | 11/17/2025 | 86.02 K | $1.03 M | -0.84% | 0.40% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 77.51 K | $927.75 K | 423.83% | 0.36% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 75.19 K | $900.07 K | 100.00% | 0.35% |
| SEI INVESTMENTS CO | 11/13/2025 | 73.85 K | $884.03 K | 0.00% | 0.35% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 60.72 K | $726.84 K | -22.60% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 60.49 K | $724.10 K | 9.05% | 0.28% |
| INVESCO LTD. | 11/13/2025 | 59.70 K | $714.59 K | -5.07% | 0.28% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 54.26 K | $649.46 K | -49.00% | 0.25% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 11/14/2025 | 50.43 K | $603.70 K | 0.00% | 0.24% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 49.98 K | $598.30 K | 100.00% | 0.23% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 48.57 K | $581.40 K | 19.11% | 0.23% |
| JANE STREET GROUP, LLC | 11/14/2025 | 44.90 K | $537.45 K | 100.00% | 0.21% |
| SKOPOS LABS, INC. | 11/14/2025 | 43.15 K | $323.65 K | 1.50% | 0.20% |
| BARCLAYS PLC | 11/12/2025 | 41.62 K | $498.20 K | -13.09% | 0.20% |
| MAN GROUP PLC | 11/14/2025 | 40.16 K | $480.67 K | 100.00% | 0.19% |
| IEQ CAPITAL, LLC | 11/14/2025 | 37.69 K | $451.10 K | -6.60% | 0.18% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 37.32 K | $446.76 K | 99.27% | 0.18% |
| QUANTINNO CAPITAL MANAGEMENT LP | 11/14/2025 | 37.13 K | $444.40 K | 200.83% | 0.17% |
| PHARVISION ADVISERS, LLC | 11/17/2025 | 35.85 K | $429.08 K | 100.00% | 0.17% |
| THRIVENT FINANCIAL FOR LUTHERANS | 11/04/2025 | 34.04 K | $407.00 K | -60.34% | 0.16% |
| BANK OF MONTREAL /CAN/ | 11/13/2025 | 33.87 K | $405.40 K | 0.00% | 0.16% |
Enanta Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 181 institutional investors and hedge funds held shares of Enanta Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FARALLON CAPITAL MANAGEMENT LLC: 2.12 M
Krensavage Asset Management, LLC: 2.11 M
JANUS HENDERSON GROUP PLC: 1.95 M
VANGUARD GROUP INC: 1.94 M
BlackRock, Inc.: 1.83 M
MILLENNIUM MANAGEMENT LLC: 948,084
89.07% of Enanta Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 25.84 M shares in the last 24 months. This purchase volume represents approximately $266.97 M in transactions.